Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
Research and Development
NAMSA expands microbiology and sterility assurance testing laboratory in Irvine, California
Development services : 28 March, 2013
NAMSA is continuing the organization's steady growth with the expansion of its microbiology laboratory in Irvine, California, USA.
 
EPSRC reveals investment plans for 15 healthcare engineering research projects
Research institutes : 08 March, 2013
The Engineering and Physical Sciences Research Council (EPSRC) reveals a £12.2 million investment in 15 creative engineering research projects, that can deliver major advances in healthcare.
 
Ugandan government health officials agree new Alliance with UK
Research institutes : 19 February, 2013
A Ugandan-UK Healthcare Alliance, which will help improve health care for people living in the East African country, is launched after being developed by a University of Manchester health professional.
 
St Jude Medical starts landmark study of renal denervation for reduction of heart attack, stroke and death
Research studies : 18 February, 2013
St Jude Medical is planning a new landmark study that will evaluate whether renal denervation and medication can provide health benefits to patients beyond lowering high blood pressure.
 
Cook Medical passes 50 percent enrollment in study of technique for treating critical limb ischemia
Research studies : 07 February, 2013
With more than 100 patients enrolled, Cook Medical exceeds 50 percent enrollment in the Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions trial.
 
Study into home monitoring for CF patients is expanded
Research studies : 05 February, 2013
ERT together with pulmonary researchers at the Johns Hopkins University School of Medicine and University of Washington, are expanding the Early Intervention in Cystic Fibrosis Exacerbation (eICE) Study.
 
Diamyd's diabetes vaccine to undergo clinical study
Research studies : 04 February, 2013
Diamyd Medical is reporting that a new clinical study with the diabetes vaccine Diamyd is planned to start in February 2013.
 
Life Technologies sets up international influenza network to monitor vaccine development
Development services : 31 January, 2013
Life Technologies is establshing the Global Influenza Network, a partnership including scientists at a number of the world's leading government public health organizations, veterinary agencies and research institutes in a collaborative effort to increase the speed and efficiency of influenza monitoring and vaccine development.
 
Gene sequencing project mines junk DNA data for cancer treatment clues
Research studies : 29 January, 2013
St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project, develops an approach to mine the repetitive segments of DNA at the ends of chromosomes for insights into cancer.
 
MIT deforms cells to deliver RNA, proteins and nanoparticles for many applications
Research studies : 25 January, 2013
Researchers from MIT discover a safe and efficient way to get large molecules through the cell membrane, by squeezing the cells through a narrow constriction that opens up tiny, temporary holes in the membrane.
 
Global paediatric Phase III pivotal study of recombinant fusion protein begins enrollment
Research studies : 24 January, 2013
CSL Behring reports that the first patient is now enrolled in the pivotal paediatric phase III study to evaluate the safety, efficacy and pharmacokinetics of recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP) in previously treated children (up to age 11 years).
 
Six translational research centres form alliance to accelerate global drug development
Research institutes : 23 January, 2013
Six of the world's top translational health research centres are coming together to form a new Global Alliance of Leading Drug Discovery and Development Centres.
 
Genetic basis of high-risk childhood cancer shows the way to new drug treatment strategies
Research studies : 22 January, 2013
Research led by St Jude Children's Research Hospital scientists identifies a possible lead in treatment of two childhood leukaemia subtypes known for their loss of chromosomes and poor treatment outcomes.
 
Nanoparticles technology aims to offer earlier cancer diagnosis solution
Research institutes : 18 December, 2012
A new technology developed at MIT aims to help to make biomarker detection much easier with researchers, led by Sangeeta Bhatia, developing nanoparticles that can home in on a tumour and interact with cancer proteins to produce thousands of biomarkers, which can then be easily detected in the patient's urine.
 
Tissue engineering research at MIT aims to discover better ways to heal injuries and develop new drugs
Research institutes : 17 December, 2012
Much of the tissue engineering research at MIT's Institute for Medical Engineering and Science is focusing on creating tissue that can be used in the lab to model human disease and test potential new drugs.
 
Cytel opens Geneva office to extend global clinical development capabilities
Development services : 04 December, 2012
Cytel is opening a new office in Geneva, Switzerland to support the growing demand for clinical research and biostatistical consulting capabilities throughout Europe.
 
New injectable gels from MIT toughen up after entering the body
Research institutes : 20 November, 2012
MIT chemical engineers have now designed an injectable gel that responds to the body's high temperature by forming a reinforcing network that makes the gel much more durable, allowing it to function over a longer period of time.
 
Study shows stereotactic radiosurgery is promising for kidney cancer
Research studies : 02 November, 2012
A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center is showing encouraging results for the use of stereotactic radiosurgery to treat kidney cancer.
 
Algometron seeks partners to develop pain test that stratifies patients for optimal therapy
Development services : 23 October, 2012
A novel patented technology (Algotect) has been developed by Algometron to accurately identify patients who are cold hyperalgesic and require specific pain management and Algometron is seeking partners interested in commercially developing (RUO, IVD, LDT, CDx) the innovative and proven device which provides real time, cost effective information to support clinicians, research, drug development and clinical trials.
 
Diamyd Medical divests US gene therapy company
Development services : 10 October, 2012
Diamyd Medical enters into an agreement for the sale of the US subsidiary, Diamyd, involved in drug development primarily relating to the NTDDS platform with applications in pain and neuropathy among others.
 
AB SCIEX partners University of Wollongong to advance lipid analysis
Development services : 19 September, 2012
AB SCIEX and the University of Wollongong (UOW) are forming a research partnership to develop lipid analysis capabilities, including the most definitive and comprehensive identification of double bond position in lipids.
 
Improved diagnostic test identifies treatment for children with acute myeloid leukemia
Research studies : 11 September, 2012
Research led by St Jude Children's Research Hospital investigators has identified the best test for measuring early treatment response for young patients with acute myeloid leukemia (AML).
 
Neuralstem completes Phase I ALS stem cell trial
Research studies : 29 August, 2012
Neuralstem completes the Phase I trial of its NSI-566 spinal cord neural stem cells for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), with the eighteenth patient treated.
 
Merging tissue scaffold with electronic sensors improve implantable therapeutic devices
Research institutes : 28 August, 2012
A team of researchers from MIT, Harvard University and Boston Children's Hospital is adding a new element to tissue scaffolds - electronic sensors.
 
Japanese researchers develop mobility system to improve the quality of life of Parkinson's disease patients
Research institutes : 28 August, 2012
Tokyo Institute of Technology's Yoshihiro Miyake and colleagues develop an innovative, non-invasive therapeutic intervention that may improve the mobility, stability, and quality of life of Parkinson's disease patients.
 
Age of father is found to more critical to new mutations being passed to offspring
Research studies : 24 August, 2012
deCODE Genetics in collaboration with Illumina reports in the journal Nature that a father's age, not a mother's, at the time a child is conceived is the single largest contributor to the passing of new hereditary mutations to offspring.
 
Research shows success of engineered tissue depends on where it is grown
Research studies : 15 August, 2012
MIT researchers led by Elazer Edelman, the Thomas D and Virginia W Cabot Professor of Health Sciences and Technology, are showing that implanted cells' therapeutic properties depend on their shape, which is determined by the type of scaffold on which they are grown. The work could allow scientists to develop even more effective implants and also target many other diseases, including cancer.
 
Quotient completes a programme to develop an optimised drug for new pain medication
Research studies : 25 July, 2012
Quotient Clinical is reporting the publication of results, in the journal Pharmaceutical Research, of a RapidFACT programme conducted for Eli Lilly.
 
PerkinElmer creates new personalized Health Innovation Center of Excellence
Development services : 08 June, 2012
PerkinElmer plans to establish a new Personalized Health Innovation Center of Excellence which will focus on accelerating scientific innovation to help researchers who are working to eradicate disease and extend the quality and longevity of life.
 
Nordion opens the Gamma Centre of Excellence in Canada
Development services : 11 May, 2012
Nordion is launching the Gamma Centre of Excellence (GCE), a world-class facility for the advancement of gamma sterilization science.
 
Nordion plans Europe-focused Phase III clinical trial for liver cancer treatment
Research studies : 25 April, 2012
Nordion is supporting an additional randomized, multi-centre Phase III clinical trial for TheraSphere, Nordion's yttrium-90 (Y-90) glass microsphere treatment for liver cancer.
 
CDISC releases new Protocol Representation Model toolkit
Research institutes : 23 April, 2012
The Clinical Data Interchange Standards Consortium (CDISC) is releasing the first iteration of a Protocol Representation 'Toolkit' for clinical research at the CDISC European Interchange Conference in Stockholm, Sweden.
 
Largest Warfarin patient self-testing study points to new standard of care
Research studies : 29 March, 2012
Alere reveals at the 2012 American College of Cardiology Summit the results from the world's largest study of warfarin (Coumadin) patient self-testers, performed by anticoagulation expert, Jack Ansell, MD, which showed that self-testing led to excellent therapy control.
 
Covidien boosts global research and development presence
Development services : 12 March, 2012
Covidien is opening of four research and development centres in Boulder, Colorado; Hyderabad, India; Irvine, California; and Trevoux, France.
 
Study finds chronic pain patients benefit from education
Research studies : 28 February, 2012
A study conducted at Mayo Pain Rehabilitation Center, Rochester, Maine, USA by Sarah Hayes and Michael Hooten, MD, Associate Professor of Anesthesiology at Mayo Clinic shows that substance use education incorporated into a cognitive behavioural rehabilitation programming is effective to improve pain and function for the chronic pain patient at high-risk for comorbid substance abuse.
 
Illumina introduces new cancer analysis service
Development services : 20 February, 2012
Illumina launches a Cancer Analysis Service from the Illumina Genome Network (IGN) that applies the high accuracy of Illumina technologies to provide cancer researchers with easily interpretable tumour/normal sequencing data to quickly move their research forward.
 
Scottish Government forges research strategic alliance with PPD
Development services : 13 February, 2012
The Scottish government and Pharmaceutical Product Development (PPD) is forming an alliance designed to increase the amount of clinical research conducted in Scotland, accelerate the development of new medical therapies and enhance health care treatment options for the people of Scotland.
 
Sequencing project links mutations with childhood brain tumours
Research studies : 01 February, 2012
Researchers at St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project provides first evidence linking cancer to mutations in genes involved in DNA organization.
 
New indicator selects patients with increased throat cancer risk
Research studies : 17 January, 2012
Researchers at the University of Michigan Health System discover a new indicator that may predict which patients with a common type of throat cancer are most likely have the cancer spread to other parts of their bodies.
 
British Columbia Cancer Agency joins the Illumina Genome Network
Development services : 20 December, 2011
The British Columbia Cancer Agency's (BCCA) Genome Science Center is joining the Illumina Genome Network (IGN) which is designed to link researchers needing large-scale whole human genome sequencing with leading institutions that provide this application as a service using industry-leading Illumina sequencing platforms.
 
Research centre for blast injury studies is launched
Research institutes : 09 December, 2011
The Royal British Legion Centre for Blast Injury Studies at Imperial College London is a new £8 million research centre being launched which aims to gain a better understanding of the injuries caused by roadside bombs and improve both treatment and the means of protection.
 
Cancer research study to target tumour-secreted exosomes
Research studies : 07 December, 2011
Aethlon Medical is reporting that a cancer research study to test the ex vivo effectiveness of the Aethlon Hemopurifier to capture tumour-secreted exosomes from the blood of advanced-stage cancer patients has received institutional review board approval to begin studies at the Sarcoma Oncology Center, based in Santa Monica, California, USA.
 
Zimmer to open research and development centre in Beijing
Development services : 05 December, 2011
Zimmer plans to establish a new research and development centre in Beijing, China with the centre becoming the foundation for a network of research and development programs across the region.
 
Research on dendrites clinches 2011 Eppendorf and Science Prize
Research studies : 17 November, 2011
The Portuguese scientist, Tiago Branco MD, PhD, Postdoctoral Research Fellow at University College London is named the winner of the 2011 Eppendorf and Science Prize for Neurobiology for his research on dendrites.
 
FDA gives Neuralstem approval to dose in cervical region in ALS trial
Research studies : 26 October, 2011
Neuralstem is updating the progress of its ongoing Phase I safety trial of the company's spinal cord stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) at Emory University in Atlanta, Georgia, USA.
 
Quintiles acquires Outcome Sciences to boost late phase research
Development services : 21 October, 2011
Quintiles acquires Outcome Sciences, a privately held outcomes research firm headquartered in Cambridge, Massachisetts, USA.
 
Personalized medicine study yields clues about patient engagement
Research studies : 18 October, 2011
The Medco Research Institute, the research subsidiary of Medco Health Solutions, and Quest Diagnostics are reporting their study showed a statistically significant increase in adherence to statin therapy over six months in patients receiving kinesin-like protein 6 (KIF6) gene testing, compared with those who did not.
 
Two rare genetic variants pinpoint risk of gout
Research studies : 11 October, 2011
Scientists at deCODE Genetics and academic collaborators from Iceland, Norway, Denmark, the Netherlands and the USA are reporting the discovery of low frequency variants in the human genome that associate with risk of gout, a common inflammatory arthritis, and serum uric acid levels.
 
Genetic risk factor for skin, prostate and brain cancers is identified
Research studies : 27 September, 2011
Scientists at deCODE Genetics and academic collaborators from Iceland, The Netherlands, Spain, Denmark, Germany, Sweden, the USA, the UK and Romania are reporting the discovery of a variant in the sequence of the human genome associated with risk of developing basal cell carcinoma of the skin (BCC), as well as prostate cancer and glioma, the most serious form of brain cancer.
 
Covidien to open flagship research and development centre in China
Development services : 19 September, 2011
Covidien says Shanghai is to become the site of the company's flagship research and development centre for China.
 
First | Prev  | 1 | 2 | 3 | 4 | 5 | 6  | Next  | Last
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo